Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts

Open Access

Peer-reviewed

Research Article

Erica E. M. Moodie,

Affiliation Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
⨯
Nitika Pant Pai,

Affiliation Divisions of Infectious Diseases/Immunodeficiency, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada
⨯
Marina B. Klein

* E-mail: marina.klein@muhc.mcgill.ca

Affiliation Divisions of Infectious Diseases/Immunodeficiency, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada
⨯

Reader Comments (0)

Highly-active antiretroviral therapy
Is the Subject Area "Highly-active antiretroviral therapy" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Liver diseases
Is the Subject Area "Liver diseases" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Co-infections
Is the Subject Area "Co-infections" applicable to this article?

Thanks for your feedback.